Related references
Note: Only part of the references are listed.Treatment Patterns for Diabetic Macular Edema: An Intelligent Research in Sight (IRIS®) Registry Analysis
Ronald A. Cantrell et al.
OPHTHALMOLOGY (2020)
Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients A Real-World Analysis of 49 485 Eyes
Thomas A. Ciulla et al.
OPHTHALMOLOGY RETINA (2020)
Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice
Nancy M. Holekamp et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)
Clinical pharmacology of intravitreal anti-VEGF drugs
Stefano Fogli et al.
EYE (2018)
Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United States
Thomas A. Ciulla et al.
OPHTHALMOLOGY RETINA (2018)
Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States
Thomas A. Ciulla et al.
OPHTHALMOLOGY RETINA (2018)
Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
Kevin J. Blinder et al.
CLINICAL OPHTHALMOLOGY (2017)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
John A. Wells et al.
OPHTHALMOLOGY (2016)
Diabetic Macular Edema Diagnosis and Treatment in the Real World: An Analysis of Medicare Claims Data (2008 to 2010)
Pravin U. Dugel et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2016)
Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort
Brian L. VanderBeek et al.
PLOS ONE (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Intravitreal Aflibercept for Diabetic Macular Edema
Jean-Francois Korobelnik et al.
OPHTHALMOLOGY (2014)
Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF
Michael W. Stewart
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
Szilard Kiss et al.
CLINICAL OPHTHALMOLOGY (2014)
Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS
Ninel Z. Gregori et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Diabetic retinopathy and diabetic macular edema - Pathophysiology, screening, and novel therapies
TA Ciulla et al.
DIABETES CARE (2003)
Share Paper
